Zymeworks to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) Conference

Zymeworks is pleased to announce the acceptance of an abstract for poster presentation at the Society for Immunotherapy of Cancer (SITC) Conference taking place in Boston, MA from November 8 to November 12, 2022.

Presentation Details:

Title: Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)
Poster Number: 1185
Date and Time: November 10, 2022 at 9:00 am – 9:00 pm ET
Location: Boston Convention & Exhibition Center, Hall C

The presentation will be available to conference registrants on the conference website as well as to the general public at www.zymeworks.com/publications at the time of presentation at the conference.